健帆生物 (300529)

Jafron Biomedical Co.,Ltd.

ASZ

Tags

Medical DevicesContains Convertible BondsGuozheng Growth IndexSmall Cap GrowthSocial Security HeavyHigh-Performing StocksHigh-Dividend StocksChiNext InnovationChiNext Large CapChiNext IndexChiNext Blue ChipChiNext HealthcareSZSE 300 IndexSZSE Growth IndexTech 100 IndexPharma & BiotechSZSE Defensive 50 IndexStable Growth IndexGreater Bay Area IndexSZSE Medicine Equal Weight IndexShenzhen A-Share Pharmaceutical IndexChiNext Equal Weight IndexCS High Dividend Yield IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexEmerging Technology 100 IndexSZSE 700 IndexSZSE Emerging Industries IndexSSE 700 Growth IndexZhongchuang Growth IndexSZSE 1000 IndexSZSE 300 Return IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnLarge & Mid-cap IndexCNI 1000 IndexBiomedicine IndexCSI Medical IndexExcellent Performance Strategy IndexSZSE Performance IndexZhongchuang Value IndexChiNext Value IndexAdvanced Manufacturing 100 IndexConvertible Bond IssuersFTSE Russell ConceptJune 2022 Lock-up ExpirySHS Greater Bay Area IndexSmall-cap High Beta IndexSZSE Responsibility IndexTechnology 50 Strategy IndexCS High-end Manufacturing IndexSZSE Technology IndexSZSE High Beta IndexSZSE ChiNext 100 IndexSZSE Pharmaceutical IndexDividend Quality IndexCSI 800 IndexCS Pharmaceutical TI IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexCNI 300 IndexCCTV 500 IndexChiNext Basic IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexSZSE 300 Equal Weight IndexChiNext Low Volatility IndexCSI 500 Equal Weight IndexSZSE Component Index Equal WeightPharmaceutical & Health 100 IndexSME & ChiNext Q IndexHigh Dividend Yield Strategy IndexCSI 700 IndexMid-small Cap IndexCSI 500 IndexCSI 500 IndexPharmaceutical 50 IndexZhongchuang High Beta IndexZhongchuang Low Volatility IndexSmall-cap Low Volatility IndexCSI 500 Growth Innovation IndexPharmaceutical 50 Strategy IndexCSI Life Sciences IndexSZSE 200 Return IndexSZSE 200 IndexCICC 300 IndexChiNext Manufacturing IndexZhongchuang 400 IndexChiNext Growth IndexCR New Momentum IndexOrient Securities Competition IndexChiNext Return IndexJuchao Mid-cap IndexSZSE 500 IndexChiNext Emerging IndexCSI 500 ESG IndexChiNext Growth IndexPerformance IndexGuangdong

K-Line Chart

No K-line data available

Company NameJianfan Biotechnology Group Co., Ltd.
Listing Date2016-08-02
Issue Price10.8RMB
Registered Capital79860.527510k RMB
Legal RepresentativeDong Fan
Registered AddressNo. 98, Keji 6th Road, High-tech Zone, Zhuhai City, Guangdong Province
IndustryMedical Devices
Main BusinessResearch, production, and sales of hemoperfusion-related products
Company ProfileZhuhai Jianfan Biotechnology Co., Ltd. was founded in 1989. It specializes in the research, development, production, and sales of biomaterials and medical devices, and is a leading enterprise in China's blood purification field. It has received the "2009 National Science and Technology Progress Second Prize", consecutively ranked in the "Forbes China Potential Enterprises Top 100 List" in 2010-2011, was recognized as a "National Torch Plan Key High-Tech Enterprise" in 2011, and was among the first batch nationwide and the second enterprise in Guangdong Province to pass the Medical Device GMP inspection.

Stock Details

1. Key Indicators

  • Total Shares(W): 79860.53
  • Circulating A-Shares(W): 51158.60
  • Earnings Per Share(RMB): 0.5900
  • Net Assets Per Share(RMB): 4.1451
  • Operating Revenue(W RMB): 155602.20
  • Total Profit(W RMB): 55205.39
  • Net Profit Attributable to Parent(W RMB): 45323.02
  • Net Profit Growth Rate(%): -42.75
  • Weighted Return on Equity(%): 13.7400
  • Operating Cash Flow Per Share(RMB): 0.7180
  • Undistributed Profit Per Share(RMB): 2.9402
  • Capital Reserve Per Share(RMB): 0.3245

2. Main Business

The main business covers:

  • Research, production and sales of biomaterials and high-tech medical devices

3. Company Basic Information

  • Company Name: Jafron Biomedical Co., Ltd.
  • Listing Date: 2016-08-02
  • Industry: Special Purpose Equipment Manufacturing
  • Address: No. 98, Keji 6th Road, High-tech Zone, Zhuhai City, Guangdong Province
  • Website: www.jafron.com
  • Company Profile：The company's predecessor was Lizhu Group Lizhu Medical Biomaterial Factory. On April 18, 2002, the shareholders' meeting of Lizhu Biomaterial Factory resolved to restructure Lizhu Biomaterial Factory into Zhuhai Lizhu Medical Biomaterial Co., Ltd. The establishment capital contribution of Lizhu Biomaterial Co., Ltd. was verified as fully paid by Zhuhai Andeli United Accounting Firm's "Andeli Verification Report (2002) No. 338-3" issued on July 12, 2002. On August 12, 2002, Lizhu Biomaterial Co., Ltd. completed its registration with the Zhuhai Administration for Industry and Commerce, with a registered capital of RMB 2 million. The company was established by the overall change of Zhuhai Jafron Biomedical Technology Co., Ltd. On December 12, 2010, all shareholders of Jafron Biomedical Co., Ltd. unanimously agreed to change the company into Zhuhai Jafron Biomedical Technology Co., Ltd. based on the audited net asset value of RMB 121,094,580.13 as of November 30, 2010, converted into 66 million shares, with the remaining RMB 55,094,580.13 included in capital reserve. This overall change capital contribution was verified as fully paid by Lianada Certified Public Accountants Co., Ltd. Zhuhai Branch's "Lianada Verification Report [2010] No. B-1053" issued on December 15, 2010, and Ruihua Certified Public Accountants (Special General Partnership)'s Ruihua Verification Report [2014] 40030033 "Verification Review Report" issued on July 30, 2014. On December 31, 2010, the company completed the registration change procedures with the Zhuhai Administration for Industry and Commerce, with a registered capital of RMB 66 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Huabao China Securities Medical ETF Fund 1349.94 2.64
2 E Fund ChiNext ETF Fund 920.02 1.80
3 China Securities 500 ETF Fund 695.95 1.36
4 Hong Kong Securities Clearing Company Ltd. Northbound Funds 621.69 1.22
5 China Merchants China Securities Bio-medicine Index Fund (LOF) Class A Fund 614.93 1.20
6 Hongtu Innovation Stable Growth Hybrid Securities Investment Fund Class A Fund 25.50 0.05
7 Hongtu Innovation Stable Hybrid Securities Investment Fund Class A Fund 7.50 0.01
8 Hongtu Innovation Stable Benefit 6-month Holding Period Hybrid Securities Investment Fund Class A Fund 5.30 0.01
9 China Merchants China Securities All Share Medical Devices ETF Initiation Link Fund Class A Fund 0.04 0.00

5. Concept Sectors

  • Convertible Bonds
  • Hepatitis Concept
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • High-Dividend Stocks
  • ChiNext Index
  • Technology 100
  • ChiNext 300
  • SZSE Innovation Index
  • ChiNext Innovation
  • ChiNext Blue Chips
  • ChiNext Medicine

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information